Summit Corporation plc Stock London S.E.
Stocks
GB00B02T3K57
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Market Cap | 9.21B 12.33B 10.79B 9.94B 17.49B 1,170B 17.77B 119B 46.35B 577B 46.27B 45.27B 1,995B | P/E 2026 * |
-14x | P/E 2027 * | -14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 8.95B 11.98B 10.48B 9.66B 16.99B 1,137B 17.27B 116B 45.04B 561B 44.96B 43.99B 1,939B | EV / Sales 2026 * |
3,657x | EV / Sales 2027 * | 219x |
| Free-Float |
16.86% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Corporation plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 54 | 25/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 01/04/2020 |
| Director of Finance/CFO | 48 | 02/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 01/02/2020 |
| Director/Board Member | 48 | 01/12/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 54 | 11/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | +1.36% | +73.32% | +128.78% | 57.72B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 52.65B | |
| +1.17% | +5.83% | +16.39% | +468.18% | 24.46B | |
| +0.38% | +1.33% | -14.32% | -11.76% | 23.84B | |
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | |
| -0.70% | +4.87% | +43.92% | -26.78% | 17.8B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 17.29B | |
| -6.73% | +9.90% | +36.04% | - | 15.28B | |
| +2.79% | +4.91% | +29.26% | +195.60% | 14.35B | |
| Average | -0.84% | +5.15% | +55.63% | +149.85% | 26.96B | |
| Weighted average by Cap. | -1.21% | +2.58% | +57.54% | +139.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.45M 3.27M 2.87M 2.64M 4.65M 311M 4.72M 31.66M 12.31M 153M 12.29M 12.03M 530M | 42.03M 56.23M 49.21M 45.35M 79.79M 5.34B 81.08M 544M 211M 2.63B 211M 207M 9.1B |
| Net income | -657M -879M -770M -709M -1.25B -83.46B -1.27B -8.5B -3.31B -41.19B -3.3B -3.23B -142B | -680M -910M -797M -734M -1.29B -86.39B -1.31B -8.8B -3.42B -42.63B -3.42B -3.34B -147B |
| Net Debt | -262M -350M -306M -282M -497M -33.23B -505M -3.39B -1.32B -16.4B -1.31B -1.29B -56.68B | -11.05M -14.78M -12.93M -11.92M -20.97M -1.4B -21.31M -143M -55.59M -692M -55.49M -54.29M -2.39B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
